APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Pain Medicines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global OTC Pain Medicines Industry Growth and Trends Forecast to 2032

2 January 2026112 pages

Choose your research edition.

Industry ResearchOTC Pain Medicines Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Pain Medicines Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal OTC Pain Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Pain Medicines Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Pain Medicines Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

According to APO Research, the global OTC Pain Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for OTC Pain Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for OTC Pain Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Pain Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the OTC Pain Medicines market include Zhejiang Kangle, Xinhua Pharmaceutical, Sanofi, Novartis, Pfizer, Hebei Jiheng, GlaxoSmithKline, Bayer and Anhui BBCA Likang, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global OTC Pain Medicines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The OTC Pain Medicines market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global OTC Pain Medicines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to OTC Pain Medicines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global OTC Pain Medicines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

OTC Pain Medicines Market by Company

Zhejiang Kangle

Xinhua Pharmaceutical

Sanofi

Novartis

Pfizer

Hebei Jiheng

GlaxoSmithKline

Bayer

Anhui BBCA Likang

Strides Shasun

Sri Krishna Pharma

Seqens

Mallinckrodt

IOLCP

Granules India

Granules Biocause

Farmson

Anqiu Lu'an

OTC Pain Medicines Segment by Type

Naproxen

Acetaminophen

Ibuprofen

Aspirin

Others

OTC Pain Medicines Segment by Application

E-Commerce

Drug Stores

Hospital Pharmacies

OTC Pain Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Pain Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Pain Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Pain Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of OTC Pain Medicines companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global OTC Pain Medicines Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global OTC Pain Medicines Market Size by Region (2021-2026) & (US$ Million) Table 3. Global OTC Pain Medicines Market Share by Region (2021-2026) Table 4. Global OTC Pain Medicines Market Size by Region (2027-2032) & (US$ Million) Table 5. Global OTC Pain Medicines Market Share by Region (2027-2032) Table 6. Global OTC Pain Medicines Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global OTC Pain Medicines Market Size by Type (2021-2026) & (US$ Million) Table 8. Global OTC Pain Medicines Market Size Share by Type (2021-2026) Table 9. Global OTC Pain Medicines Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global OTC Pain Medicines Market Size Share Forecasted by Type (2027-2032) Table 11. North America OTC Pain Medicines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America OTC Pain Medicines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe OTC Pain Medicines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe OTC Pain Medicines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific OTC Pain Medicines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific OTC Pain Medicines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America OTC Pain Medicines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America OTC Pain Medicines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa OTC Pain Medicines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa OTC Pain Medicines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global OTC Pain Medicines Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global OTC Pain Medicines Market Size by Application (2021-2026) & (US$ Million) Table 23. Global OTC Pain Medicines Market Size Share by Application (2021-2026) Table 24. Global OTC Pain Medicines Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global OTC Pain Medicines Market Size Share Forecasted by Application (2027-2032) Table 26. North America OTC Pain Medicines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America OTC Pain Medicines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe OTC Pain Medicines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe OTC Pain Medicines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific OTC Pain Medicines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific OTC Pain Medicines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America OTC Pain Medicines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America OTC Pain Medicines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa OTC Pain Medicines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa OTC Pain Medicines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. OTC Pain Medicines Industry Trends Table 37. OTC Pain Medicines Industry Drivers Table 38. OTC Pain Medicines Industry Opportunities and Challenges Table 39. OTC Pain Medicines Industry Restraints Table 40. Global OTC Pain Medicines Revenue by Company (US$ Million) & (2021-2026) Table 41. Global OTC Pain Medicines Revenue Market Share by Company (2021-2026) Table 42. Global OTC Pain Medicines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global OTC Pain Medicines Key Company Headquarters & Area Served Table 44. Global OTC Pain Medicines Company, Product Type & Application Table 45. Global OTC Pain Medicines Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global OTC Pain Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Zhejiang Kangle Company Information Table 49. Zhejiang Kangle Business Overview Table 50. Zhejiang Kangle OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Zhejiang Kangle OTC Pain Medicines Product Portfolio Table 52. Zhejiang Kangle Recent Development Table 53. Xinhua Pharmaceutical Company Information Table 54. Xinhua Pharmaceutical Business Overview Table 55. Xinhua Pharmaceutical OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Xinhua Pharmaceutical OTC Pain Medicines Product Portfolio Table 57. Xinhua Pharmaceutical Recent Development Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sanofi OTC Pain Medicines Product Portfolio Table 62. Sanofi Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Novartis OTC Pain Medicines Product Portfolio Table 67. Novartis Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pfizer OTC Pain Medicines Product Portfolio Table 72. Pfizer Recent Development Table 73. Hebei Jiheng Company Information Table 74. Hebei Jiheng Business Overview Table 75. Hebei Jiheng OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Hebei Jiheng OTC Pain Medicines Product Portfolio Table 77. Hebei Jiheng Recent Development Table 78. GlaxoSmithKline Company Information Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline OTC Pain Medicines Product Portfolio Table 82. GlaxoSmithKline Recent Development Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Bayer OTC Pain Medicines Product Portfolio Table 87. Bayer Recent Development Table 88. Anhui BBCA Likang Company Information Table 89. Anhui BBCA Likang Business Overview Table 90. Anhui BBCA Likang OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Anhui BBCA Likang OTC Pain Medicines Product Portfolio Table 92. Anhui BBCA Likang Recent Development Table 93. Strides Shasun Company Information Table 94. Strides Shasun Business Overview Table 95. Strides Shasun OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Strides Shasun OTC Pain Medicines Product Portfolio Table 97. Strides Shasun Recent Development Table 98. Sri Krishna Pharma Company Information Table 99. Sri Krishna Pharma Business Overview Table 100. Sri Krishna Pharma OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sri Krishna Pharma OTC Pain Medicines Product Portfolio Table 102. Sri Krishna Pharma Recent Development Table 103. Seqens Company Information Table 104. Seqens Business Overview Table 105. Seqens OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Seqens OTC Pain Medicines Product Portfolio Table 107. Seqens Recent Development Table 108. Mallinckrodt Company Information Table 109. Mallinckrodt Business Overview Table 110. Mallinckrodt OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Mallinckrodt OTC Pain Medicines Product Portfolio Table 112. Mallinckrodt Recent Development Table 113. IOLCP Company Information Table 114. IOLCP Business Overview Table 115. IOLCP OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. IOLCP OTC Pain Medicines Product Portfolio Table 117. IOLCP Recent Development Table 118. Granules India Company Information Table 119. Granules India Business Overview Table 120. Granules India OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Granules India OTC Pain Medicines Product Portfolio Table 122. Granules India Recent Development Table 123. Granules Biocause Company Information Table 124. Granules Biocause Business Overview Table 125. Granules Biocause OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Granules Biocause OTC Pain Medicines Product Portfolio Table 127. Granules Biocause Recent Development Table 128. Farmson Company Information Table 129. Farmson Business Overview Table 130. Farmson OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Farmson OTC Pain Medicines Product Portfolio Table 132. Farmson Recent Development Table 133. Anqiu Lu'an Company Information Table 134. Anqiu Lu'an Business Overview Table 135. Anqiu Lu'an OTC Pain Medicines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Anqiu Lu'an OTC Pain Medicines Product Portfolio Table 137. Anqiu Lu'an Recent Development Table 138. North America OTC Pain Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America OTC Pain Medicines Market Size by Country (2021-2026) & (US$ Million) Table 140. North America OTC Pain Medicines Market Share by Country (2021-2026) Table 141. North America OTC Pain Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America OTC Pain Medicines Market Share Forecast by Country (2027-2032) Table 143. Europe OTC Pain Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe OTC Pain Medicines Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe OTC Pain Medicines Market Share by Country (2021-2026) Table 146. Europe OTC Pain Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe OTC Pain Medicines Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific OTC Pain Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific OTC Pain Medicines Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific OTC Pain Medicines Market Share by Country (2021-2026) Table 151. Asia-Pacific OTC Pain Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific OTC Pain Medicines Market Share Forecast by Country (2027-2032) Table 153. Latin America OTC Pain Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America OTC Pain Medicines Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America OTC Pain Medicines Market Share by Country (2021-2026) Table 156. Latin America OTC Pain Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America OTC Pain Medicines Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa OTC Pain Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa OTC Pain Medicines Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa OTC Pain Medicines Market Share by Country (2021-2026) Table 161. Middle East & Africa OTC Pain Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa OTC Pain Medicines Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. OTC Pain Medicines Product Image Figure 3. Global OTC Pain Medicines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global OTC Pain Medicines Market Size (2021-2032) & (US$ Million) Figure 5. Global OTC Pain Medicines Market Share by Region: 2025 VS 2032 Figure 6. Global OTC Pain Medicines Market Share by Region (2021-2032) Figure 7. North America OTC Pain Medicines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe OTC Pain Medicines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific OTC Pain Medicines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America OTC Pain Medicines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa OTC Pain Medicines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Naproxen Image Figure 13. Global Naproxen Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Acetaminophen Image Figure 15. Global Acetaminophen Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Ibuprofen Image Figure 17. Global Ibuprofen Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Aspirin Image Figure 19. Global Aspirin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global OTC Pain Medicines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global OTC Pain Medicines Market Share by Type 2025 VS 2032 Figure 24. North America OTC Pain Medicines Market Size Share by Type (2021-2032) Figure 25. Europe OTC Pain Medicines Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific OTC Pain Medicines Market Size Share by Type (2021-2032) Figure 27. Latin America OTC Pain Medicines Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa OTC Pain Medicines Market Size Share by Type (2021-2032) Figure 29. E-Commerce Image Figure 30. Global E-Commerce Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Drug Stores Image Figure 32. Global Drug Stores Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Hospital Pharmacies Image Figure 34. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global OTC Pain Medicines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global OTC Pain Medicines Market Share by Application 2025 VS 2032 Figure 37. North America OTC Pain Medicines Market Size Share by Application (2021-2032) Figure 38. Europe OTC Pain Medicines Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific OTC Pain Medicines Market Size Share by Application (2021-2032) Figure 40. Latin America OTC Pain Medicines Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa OTC Pain Medicines Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 OTC Pain Medicines Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America OTC Pain Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America OTC Pain Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America OTC Pain Medicines Market Share by Country (2021-2032) Figure 47. Europe OTC Pain Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe OTC Pain Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe OTC Pain Medicines Market Share by Country (2021-2032) Figure 50. Asia-Pacific OTC Pain Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific OTC Pain Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific OTC Pain Medicines Market Share by Country (2021-2032) Figure 53. Latin America OTC Pain Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America OTC Pain Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America OTC Pain Medicines Market Share by Country (2021-2032) Figure 56. Middle East & Africa OTC Pain Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa OTC Pain Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa OTC Pain Medicines Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Naproxen
  • Acetaminophen
  • Ibuprofen
  • Aspirin
  • Others
Applications
  • E-Commerce
  • Drug Stores
  • Hospital Pharmacies
Companies covered
  • Zhejiang Kangle
  • Xinhua Pharmaceutical
  • Sanofi
  • Novartis
  • Pfizer
  • Hebei Jiheng
  • GlaxoSmithKline
  • Bayer
  • Anhui BBCA Likang
  • Strides Shasun
  • Sri Krishna Pharma
  • Seqens
  • Mallinckrodt
  • IOLCP
  • Granules India
  • Granules Biocause
  • Farmson
  • Anqiu Lu'an

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global OTC Pain Medicines Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global OTC Pain Medicines Market Size by Region (2021-2032)
  5. 1.4.1 Global OTC Pain Medicines Market Size by Region (2021-2026)
  6. 1.4.2 Global OTC Pain Medicines Market Size by Region (2027-2032)
  7. 1.5 Key Regions OTC Pain Medicines Market Size (2021-2032)
  8. 1.5.1 North America OTC Pain Medicines Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe OTC Pain Medicines Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific OTC Pain Medicines Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America OTC Pain Medicines Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa OTC Pain Medicines Market Size Growth Rate (2021-2032)
2 OTC Pain Medicines Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Naproxen
  3. 2.1.2 Acetaminophen
  4. 2.1.3 Ibuprofen
  5. 2.1.4 Aspirin
  6. 2.1.5 Others
  7. 2.2 Global OTC Pain Medicines Market Size by Type
  8. 2.2.1 Global OTC Pain Medicines Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global OTC Pain Medicines Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global OTC Pain Medicines Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global OTC Pain Medicines Market Size by Regions
  12. 2.3.1 North America OTC Pain Medicines Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe OTC Pain Medicines Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific OTC Pain Medicines Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America OTC Pain Medicines Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa OTC Pain Medicines Market Size Breakdown by Type (2021-2026)
3 OTC Pain Medicines Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 E-Commerce
  3. 3.1.2 Drug Stores
  4. 3.1.3 Hospital Pharmacies
  5. 3.2 Global OTC Pain Medicines Market Size by Application
  6. 3.2.1 Global OTC Pain Medicines Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global OTC Pain Medicines Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global OTC Pain Medicines Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global OTC Pain Medicines Market Size by Regions
  10. 3.3.1 North America OTC Pain Medicines Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe OTC Pain Medicines Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific OTC Pain Medicines Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America OTC Pain Medicines Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa OTC Pain Medicines Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 OTC Pain Medicines Industry Trends
  2. 4.2 OTC Pain Medicines Industry Drivers
  3. 4.3 OTC Pain Medicines Industry Opportunities and Challenges
  4. 4.4 OTC Pain Medicines Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by OTC Pain Medicines Revenue (2021-2026)
  2. 5.2 Global OTC Pain Medicines Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global OTC Pain Medicines Key Company Headquarters & Area Served
  4. 5.4 Global OTC Pain Medicines Company, Product Type & Application
  5. 5.5 Global OTC Pain Medicines Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global OTC Pain Medicines Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 OTC Pain Medicines Players Market Share by Revenue in 2025
  9. 5.6.3 2025 OTC Pain Medicines Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Zhejiang Kangle
  2. 6.1.1 Zhejiang Kangle Company Information
  3. 6.1.2 Zhejiang Kangle Business Overview
  4. 6.1.3 Zhejiang Kangle OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Kangle OTC Pain Medicines Product Portfolio
  6. 6.1.5 Zhejiang Kangle Recent Developments
  7. 6.2 Xinhua Pharmaceutical
  8. 6.2.1 Xinhua Pharmaceutical Company Information
  9. 6.2.2 Xinhua Pharmaceutical Business Overview
  10. 6.2.3 Xinhua Pharmaceutical OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Xinhua Pharmaceutical OTC Pain Medicines Product Portfolio
  12. 6.2.5 Xinhua Pharmaceutical Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi OTC Pain Medicines Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Novartis OTC Pain Medicines Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer OTC Pain Medicines Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Hebei Jiheng
  32. 6.6.1 Hebei Jiheng Company Information
  33. 6.6.2 Hebei Jiheng Business Overview
  34. 6.6.3 Hebei Jiheng OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Hebei Jiheng OTC Pain Medicines Product Portfolio
  36. 6.6.5 Hebei Jiheng Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline OTC Pain Medicines Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Bayer OTC Pain Medicines Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 Anhui BBCA Likang
  50. 6.9.1 Anhui BBCA Likang Company Information
  51. 6.9.2 Anhui BBCA Likang Business Overview
  52. 6.9.3 Anhui BBCA Likang OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Anhui BBCA Likang OTC Pain Medicines Product Portfolio
  54. 6.9.5 Anhui BBCA Likang Recent Developments
  55. 6.10 Strides Shasun
  56. 6.10.1 Strides Shasun Company Information
  57. 6.10.2 Strides Shasun Business Overview
  58. 6.10.3 Strides Shasun OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Strides Shasun OTC Pain Medicines Product Portfolio
  60. 6.10.5 Strides Shasun Recent Developments
  61. 6.11 Sri Krishna Pharma
  62. 6.11.1 Sri Krishna Pharma Company Information
  63. 6.11.2 Sri Krishna Pharma Business Overview
  64. 6.11.3 Sri Krishna Pharma OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sri Krishna Pharma OTC Pain Medicines Product Portfolio
  66. 6.11.5 Sri Krishna Pharma Recent Developments
  67. 6.12 Seqens
  68. 6.12.1 Seqens Company Information
  69. 6.12.2 Seqens Business Overview
  70. 6.12.3 Seqens OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Seqens OTC Pain Medicines Product Portfolio
  72. 6.12.5 Seqens Recent Developments
  73. 6.13 Mallinckrodt
  74. 6.13.1 Mallinckrodt Company Information
  75. 6.13.2 Mallinckrodt Business Overview
  76. 6.13.3 Mallinckrodt OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Mallinckrodt OTC Pain Medicines Product Portfolio
  78. 6.13.5 Mallinckrodt Recent Developments
  79. 6.14 IOLCP
  80. 6.14.1 IOLCP Company Information
  81. 6.14.2 IOLCP Business Overview
  82. 6.14.3 IOLCP OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 IOLCP OTC Pain Medicines Product Portfolio
  84. 6.14.5 IOLCP Recent Developments
  85. 6.15 Granules India
  86. 6.15.1 Granules India Company Information
  87. 6.15.2 Granules India Business Overview
  88. 6.15.3 Granules India OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Granules India OTC Pain Medicines Product Portfolio
  90. 6.15.5 Granules India Recent Developments
  91. 6.16 Granules Biocause
  92. 6.16.1 Granules Biocause Company Information
  93. 6.16.2 Granules Biocause Business Overview
  94. 6.16.3 Granules Biocause OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Granules Biocause OTC Pain Medicines Product Portfolio
  96. 6.16.5 Granules Biocause Recent Developments
  97. 6.17 Farmson
  98. 6.17.1 Farmson Company Information
  99. 6.17.2 Farmson Business Overview
  100. 6.17.3 Farmson OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Farmson OTC Pain Medicines Product Portfolio
  102. 6.17.5 Farmson Recent Developments
  103. 6.18 Anqiu Lu'an
  104. 6.18.1 Anqiu Lu'an Company Information
  105. 6.18.2 Anqiu Lu'an Business Overview
  106. 6.18.3 Anqiu Lu'an OTC Pain Medicines Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Anqiu Lu'an OTC Pain Medicines Product Portfolio
  108. 6.18.5 Anqiu Lu'an Recent Developments
7 North America
  1. 7.1 North America OTC Pain Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America OTC Pain Medicines Market Size by Country (2021-2026)
  3. 7.3 North America OTC Pain Medicines Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe OTC Pain Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe OTC Pain Medicines Market Size by Country (2021-2026)
  3. 8.3 Europe OTC Pain Medicines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific OTC Pain Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific OTC Pain Medicines Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific OTC Pain Medicines Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America OTC Pain Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America OTC Pain Medicines Market Size by Country (2021-2026)
  3. 10.3 South America OTC Pain Medicines Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa OTC Pain Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa OTC Pain Medicines Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa OTC Pain Medicines Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst